Applied Therapeutics Inc (NASDAQ: APLT) on Tuesday, plunged -7.59% from the previous trading day, before settling in for the closing price of $0.13. Within the past 52 weeks, APLT’s price has moved between $0.10 and $1.50.
Annual sales at Healthcare sector company grew by 26.57% over the past five years. The company achieved an average annual earnings per share of 29.93%. With a float of $133.23 million, this company’s outstanding shares have now reached $144.30 million.
Let’s look at the performance matrix of the company that is accounted for 35 employees.
Applied Therapeutics Inc (APLT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 7.70%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Dec 16 ’25, was worth 4,816. In this transaction Director of this company sold 43,000 shares at a rate of $0.11, taking the stock ownership to the 65,000 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director proposed sale 43,000 for $0.22, making the entire transaction worth $9,331.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.33 earnings per share (EPS) for the period topping the consensus outlook (set at -0.17) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.95% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 0.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 6.0 million, a positive change from its year-to-date volume of 5.64 million. As of the previous 9 days, the stock’s Stochastic %D was 14.90%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 1.12%, which indicates a significant decrease from 9.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0197 in the past 14 days, which was lower than the 0.0830 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6242, while its 200-day Moving Average is $0.5109. Nevertheless, the first resistance level for the watch stands at $0.1273 in the near term. At $0.1390, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1461. If the price goes on to break the first support level at $0.1085, it is likely to go to the next support level at $0.1014. Assuming the price breaks the second support level, the third support level stands at $0.0897.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 16.70 million based on 144,301K outstanding shares. Right now, sales total 460 K and income totals -105,620 K. The company made 1,000 K in profit during its latest quarter, and -18,990 K in sales during its previous quarter.
